Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1987 Dec;56(6):814–819. doi: 10.1038/bjc.1987.296

Breast cancer and atypia among young and middle-aged women: a study of 110 medicolegal autopsies.

M Nielsen 1, J L Thomsen 1, S Primdahl 1, U Dyreborg 1, J A Andersen 1
PMCID: PMC2002422  PMID: 2829956

Abstract

In 110 consecutive, medicolegal autopsies of young and middle-aged women (range 20-54 years) the breasts were examined by an extensive histopathologic method and by correlative specimen radiography. Malignancy was found in 22 women (20%) of which only one was known to have had clinical invasive breast cancer (IBC). At autopsy 2 women had IBC (2%), the remaining in situ carcinoma (in situ BC) of microfocal type (18%), i.e. 15 (14%) intraductal carcinomas (DCIS), 4 (3%) lobular carcinoma in situ (LCIS) and one (1%) both DCIS and LCIS. Forty-five per cent of the women with malignancy had multicentric and 41% had bilateral lesions. Forty-five per cent of all histologically confirmed malignant lesions were identified by specimen radiography. Adenosis, benign epithelial hyperplasia, papilloma and duct ectasia were positively associated with malignancy. In addition malignancy was significantly more frequent among women aged more than 40 years, with late age at first full-term pregnancy, with alcohol abuse and with steatosis or cirrhosis of the liver. The results suggest that clinically occult in situ BC are frequent in young and middle-aged women.

Full text

PDF
814

Images in this article

815Figure 1
on p.815
815Figure 2
on p.815
815Figure 3
on p.815
815Figure 4
on p.815
816Figure 5
on p.816
816Figure 6
on p.816
816Figure 7
on p.816

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alpers C. E., Wellings S. R. The prevalence of carcinoma in situ in normal and cancer-associated breasts. Hum Pathol. 1985 Aug;16(8):796–807. doi: 10.1016/s0046-8177(85)80251-3. [DOI] [PubMed] [Google Scholar]
  2. Andersen J. A., Schiodt T. On the concept of carcinoma in situ of the breast. Pathol Res Pract. 1980;166(4):407–414. doi: 10.1016/S0344-0338(80)80241-X. [DOI] [PubMed] [Google Scholar]
  3. Andersen J. A., Vendelboe M. L. Cytoplasmic mucous globules in lobular carcinoma in situ. Diagnosis and prognosis. Am J Surg Pathol. 1981 Apr;5(3):251–255. doi: 10.1097/00000478-198104000-00005. [DOI] [PubMed] [Google Scholar]
  4. Asnaes S., Paaske F. Uncertainty of determining mode of death in medicolegal material without autopsy--a systematic autopsy study. Forensic Sci Int. 1980 Jan-Feb;15(1):3–17. doi: 10.1016/0379-0738(80)90190-5. [DOI] [PubMed] [Google Scholar]
  5. Betsill W. L., Jr, Rosen P. P., Lieberman P. H., Robbins G. F. Intraductal carcinoma. Long-term follow-up after treatment by biopsy alone. JAMA. 1978 May 5;239(18):1863–1867. doi: 10.1001/jama.239.18.1863. [DOI] [PubMed] [Google Scholar]
  6. Cady B. Total mastectomy and partial axillary dissection. Surg Clin North Am. 1973 Apr;53(2):313–318. doi: 10.1016/s0039-6109(16)39983-2. [DOI] [PubMed] [Google Scholar]
  7. Danielson D. A., Jick H., Hunter J. R., Stergachis A., Madsen S. Nonestrogenic drugs and breast cancer. Am J Epidemiol. 1982 Aug;116(2):329–332. doi: 10.1093/oxfordjournals.aje.a113416. [DOI] [PubMed] [Google Scholar]
  8. Fisher E. R., Sass R., Fisher B., Wickerham L., Paik S. M. Pathologic findings from the National Surgical Adjuvant Breast Project (protocol 6). I. Intraductal carcinoma (DCIS). Cancer. 1986 Jan 15;57(2):197–208. doi: 10.1002/1097-0142(19860115)57:2<197::aid-cncr2820570203>3.0.co;2-n. [DOI] [PubMed] [Google Scholar]
  9. Gallager H. S. The developmental pathology of breast cancer. Cancer. 1980 Aug 15;46(4 Suppl):905–907. doi: 10.1002/1097-0142(19800815)46:4+<905::aid-cncr2820461309>3.0.co;2-p. [DOI] [PubMed] [Google Scholar]
  10. Holland R., Hendriks J. H., Mravunac M. Mammographically occult breast cancer. A pathologic and radiologic study. Cancer. 1983 Nov 15;52(10):1810–1819. doi: 10.1002/1097-0142(19831115)52:10<1810::aid-cncr2820521009>3.0.co;2-f. [DOI] [PubMed] [Google Scholar]
  11. Kelsey J. L. A review of the epidemiology of human breast cancer. Epidemiol Rev. 1979;1:74–109. doi: 10.1093/oxfordjournals.epirev.a036215. [DOI] [PubMed] [Google Scholar]
  12. Kramer W. M., Rush B. F., Jr Mammary duct proliferation in the elderly. A histopathologic study. Cancer. 1973 Jan;31(1):130–137. doi: 10.1002/1097-0142(197301)31:1<130::aid-cncr2820310117>3.0.co;2-n. [DOI] [PubMed] [Google Scholar]
  13. Lagios M. D., Westdahl P. R., Margolin F. R., Rose M. R. Duct carcinoma in situ. Relationship of extent of noninvasive disease to the frequency of occult invasion, multicentricity, lymph node metastases, and short-term treatment failures. Cancer. 1982 Oct 1;50(7):1309–1314. doi: 10.1002/1097-0142(19821001)50:7<1309::aid-cncr2820500716>3.0.co;2-#. [DOI] [PubMed] [Google Scholar]
  14. Moskowitz M. Mammographic screening: significance of minimal breast cancers. AJR Am J Roentgenol. 1981 Apr;136(4):735–738. doi: 10.2214/ajr.136.4.735. [DOI] [PubMed] [Google Scholar]
  15. Moskowitz M. The predictive value of certain mammographic signs in screening for breast cancer. Cancer. 1983 Mar 15;51(6):1007–1011. doi: 10.1002/1097-0142(19830315)51:6<1007::aid-cncr2820510607>3.0.co;2-p. [DOI] [PubMed] [Google Scholar]
  16. Nielsen M., Christensen L., Andersen J. Contralateral cancerous breast lesions in women with clinical invasive breast carcinoma. Cancer. 1986 Mar 1;57(5):897–903. doi: 10.1002/1097-0142(19860301)57:5<897::aid-cncr2820570502>3.0.co;2-t. [DOI] [PubMed] [Google Scholar]
  17. Nielsen M., Jensen J., Andersen J. Precancerous and cancerous breast lesions during lifetime and at autopsy. A study of 83 women. Cancer. 1984 Aug 15;54(4):612–615. doi: 10.1002/1097-0142(1984)54:4<612::aid-cncr2820540403>3.0.co;2-b. [DOI] [PubMed] [Google Scholar]
  18. Ohuchi N., Abe R., Kasai M. Possible cancerous change of intraductal papillomas of the breast. A 3-D reconstruction study of 25 cases. Cancer. 1984 Aug 15;54(4):605–611. doi: 10.1002/1097-0142(1984)54:4<605::aid-cncr2820540402>3.0.co;2-6. [DOI] [PubMed] [Google Scholar]
  19. Oral-contraceptive use and the risk of breast cancer. The Cancer and Steroid Hormone Study of the Centers for Disease Control and the National Institute of Child Health and Human Development. N Engl J Med. 1986 Aug 14;315(7):405–411. doi: 10.1056/NEJM198608143150701. [DOI] [PubMed] [Google Scholar]
  20. Page D. L., Dupont W. D., Rogers L. W., Landenberger M. Intraductal carcinoma of the breast: follow-up after biopsy only. Cancer. 1982 Feb 15;49(4):751–758. doi: 10.1002/1097-0142(19820215)49:4<751::aid-cncr2820490426>3.0.co;2-y. [DOI] [PubMed] [Google Scholar]
  21. Page D. L., Vander Zwaag R., Rogers L. W., Williams L. T., Walker W. E., Hartmann W. H. Relation between component parts of fibrocystic disease complex and breast cancer. J Natl Cancer Inst. 1978 Oct;61(4):1055–1063. [PubMed] [Google Scholar]
  22. Rosen P. P., Braun D. W., Jr, Kinne D. E. The clinical significance of pre-invasive breast carcinoma. Cancer. 1980 Aug 15;46(4 Suppl):919–925. doi: 10.1002/1097-0142(19800815)46:4+<919::aid-cncr2820461311>3.0.co;2-z. [DOI] [PubMed] [Google Scholar]
  23. Rosenberg L., Slone D., Shapiro S., Kaufman D. W., Helmrich S. P., Miettinen O. S., Stolley P. D., Levy M., Rosenshein N. B., Schottenfeld D. Breast cancer and alcoholic-beverage consumption. Lancet. 1982 Jan 30;1(8266):267–270. doi: 10.1016/s0140-6736(82)90987-4. [DOI] [PubMed] [Google Scholar]
  24. Schwartz G. F., Patchesfsky A. S., Feig S. A., Shaber G. S., Schwartz A. B. Multicentricity of non-palpable breast cancer. Cancer. 1980 Jun 15;45(12):2913–2916. doi: 10.1002/1097-0142(19800615)45:12<2913::aid-cncr2820451202>3.0.co;2-0. [DOI] [PubMed] [Google Scholar]
  25. Tabár L., Fagerberg C. J., Gad A., Baldetorp L., Holmberg L. H., Gröntoft O., Ljungquist U., Lundström B., Månson J. C., Eklund G. Reduction in mortality from breast cancer after mass screening with mammography. Randomised trial from the Breast Cancer Screening Working Group of the Swedish National Board of Health and Welfare. Lancet. 1985 Apr 13;1(8433):829–832. doi: 10.1016/s0140-6736(85)92204-4. [DOI] [PubMed] [Google Scholar]
  26. Urban J. A. Bilateral breast cancer. Cancer. 1969 Dec;24(6):1310–1313. doi: 10.1002/1097-0142(196912)24:6<1310::aid-cncr2820240644>3.0.co;2-6. [DOI] [PubMed] [Google Scholar]
  27. Webber B. L., Heise H., Neifeld J. P., Costa J. Risk of subsequent contralateral breast carcinoma in a population of patients with in-situ breast carcinoma. Cancer. 1981 Jun 15;47(12):2928–2932. doi: 10.1002/1097-0142(19810615)47:12<2928::aid-cncr2820471232>3.0.co;2-5. [DOI] [PubMed] [Google Scholar]
  28. Wellings S. R., Jensen H. M. On the origin and progression of ductal carcinoma in the human breast. J Natl Cancer Inst. 1973 May;50(5):1111–1118. doi: 10.1093/jnci/50.5.1111. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES